BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ)

$4.725 -0.915 (-16.2234%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 70

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) News Sources

bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference

22-09-2026

yahoo.com

bioAffinity Technologies to Showcase Lung Cancer Test Data at Veterans’ Research Conference

22-09-2026

advfn.com

bioAffinity Technologies Builds Momentum for Non-Invasive Lung Cancer Detection

28-09-2026

advfn.com

bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL

30-09-2026

yahoo.com

bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026

06-10-2026

yahoo.com

bioAffinity Technologies Receives Japanese Patent Allowance for CyPath Lung AI Diagnostic Test

08-10-2026

advfn.com

bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

08-10-2026

yahoo.com

WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

08-10-2026

yahoo.com

bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

09-10-2026

yahoo.com

WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

09-10-2026

yahoo.com

BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) Sentiment Trend

0 25 50 75 100 88 90 89 88 91 64 85 85 3 16 22-09-2026 28-09-2026 30-09-2026 06-10-2026 08-10-2026 09-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) FAQs

toggle

What is the current price of BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ)?

The current price of BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) is $4.725.


toggle

BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) since the previous trading day is $-0.915.


toggle

BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) since the previous trading day is -16.2234%.


toggle

What is the most recent average sentiment score for BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ)?

The most recent average sentiment score for BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) is 70 out of 100.


toggle

What is the most recent average sentiment for BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ)?

The most recent sentiment for BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ) is .


SEC-8K** Filing Available For BIOAFFINITY TECHNOLOGIES INC (BIAF:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.